Accretion Pharmaceuticals Limited
Accretion Pharmaceuticals Limited was a SME-platform initial public offer.
The book was open from 14 May 2025 to 16 May 2025.
The issue was priced at ₹101 a share, from a band of ₹96 to ₹101.
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
The shares listed on 21 May 2025.
This issue has no ISIN on file, so its listed price history cannot be matched.
- Registrar
- Kfin Technologies Limited
- Lead manager
- Jawa Capital Services Private Limited
- Bidding opens14 May 2025
- Bidding closes16 May 2025
- Basis of allotmentnot published
Not published in the exchange feeds we ingest — we do not estimate it.
- Listing21 May 2025
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
We have not extracted an anchor allotment list for this issue.
- All other pre-issue capitalSEBI ICDR 2018 Reg. 17 — all other pre-issue capital, 6 months from allotment21 Nov 2025already free
- Promoters' minimum contributionSEBI ICDR 2018 Reg. 16(1)(a) — promoters' minimum contribution, 18 months from allotment21 Nov 2026whole tranche releases on this date
Computed from the SEBI ICDR 2018 lock-in rules, not disclosed by the issuer or the exchange. The regulation counts from the date of allotment, which no feed we ingest publishes, so these are counted from the listing date and fall at most two to three business days later than the true expiry.
The "Basis for Offer Price" chapter states the earnings the price was set against and the multiples it implies. We have not extracted it for this issue — several offer documents are served as .zip archives or as scanned pages with no text layer.
We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.
We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.
The peer table is printed in the offer document's "Basis for Offer Price" chapter; we have not extracted it for this issue yet.
The issuer's own figures as printed at the head of the same table — its claim about itself, on the same basis as its claims about the companies below.
| Firm | Issues | Typical listing move | Below issue @30d | @90d | @180d |
|---|---|---|---|---|---|
Jawa Capital Services Private Limited 2025 – 2025 | 1 0 measurable | — | — | — | — |
| Firm | Issues | Typical listing move | Below issue @30d | @90d | @180d |
|---|---|---|---|---|---|
Kfin Technologies Limited 2021 – 2026 | 140 46 measurable | +8.9% | 20 of 41 | 5 of 11 | 3 of 7 |
A count of what happened to the other issues each firm was named on, computed from exchange closes. Not a rating, not a ranking, and not a view on the firm.
- Prospectus· PDF · exchange archive6 May 2025NO_TABLE
- Red herring prospectus (RHP)· ZIP · exchange archive6 May 2025
- Draft red herring prospectus (DRHP)· PDF · exchange archive8 Jan 2025
- Draft red herring prospectus (DRHP)· ZIP · exchange archive17 Sept 2024
- Draft red herring prospectus (DRHP)· PDF · exchange archive16 Sept 2024
Filed with SEBI and the exchanges by the issuer. These are the source for every figure on this page.
Compiled from NSE and SEBI offer documents and exchange feeds. A description of the issue and of the bids received — not investment advice, and not a view on whether to apply. No grey-market premium, no allotment lookup and no listing-gain estimate is published here.